ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oncology Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Published Date: June 2024
|
Report Code: QYRE-Auto-4R430
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Oncology Drugs Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Oncology Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030

Code: QYRE-Auto-4R430
Report
June 2024
Pages:196
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
Astrazeneca plc
Sanofi
Novartis
Celgene
Bristol–Myers Squibb
Johnson & Johnson
Merck
Pfizer Inc
Amgen Inc
Eli Lilly
AbbVie
Takeda
Astellas
Ipsen S A
Bayer
Biogen Idec
TEVA
Otsuka
Eisai Co Ltd
Merck KGaA
Gilead Sciences

Oncology Drugs Market Size

The global market for Oncology Drugs was estimated to be worth US$ 197440 million in 2023 and is forecast to a readjusted size of US$ 395270 million by 2030 with a CAGR of 10.3% during the forecast period 2024-2030.

Oncology Drugs Market

Oncology Drugs Market

Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified.
When these extra cells form a mass or a solid lump of tissue, it is called a tumor. Most cancers form tumors, but not all do. Tumors may be either benign or cancerous.
Benign tumors do not spread to other parts of the body and are rarely life-threatening. Many breast lumps, for example, are benign. Benign tumors are not cancer.
Malignant tumors crowd out healthy cells, interfere with body functions, and draw nutrients from body tissues. Malignant tumors can also spread to other parts of the body via the blood or lymphatic system, forming satellite tumors, called secondary cancers or metastases. Malignant tumors are cancer.
The industry's leading producers include Roche, Celgene and Novartis, which together account for 35% of their revenues. By region, North America had the highest share of income, at 43%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oncology Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Oncology Drugs.
The Oncology Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oncology Drugs market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncology Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation

Scope of Oncology Drugs Market Report

Report Metric Details
Report Name Oncology Drugs Market
Forecasted market size in 2030 US$ 395270 million
CAGR 10.3%
Forecasted years 2024 - 2030
Segment by Type
  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy (Biologic Therapy)
  • Hormonal Therapy
  • Others
Segment by Application
  • Blood Cancer
  • Breast Cancer
  • Gastrointestinal Cancer
  • Prostate Cancer
  • Respiratory or Lung Cancer
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, Celgene, Novartis, Bristol-Myers Squibb, Johnson & Johnson, Merck & Co., AstraZeneca, Pfizer, Amgen, Eli Lilly, AbbVie, Takeda, Astellas, Ipsen, Sanofi, Bayer, Biogen Idec, Teva, Otsuka, Eisai, Merck KGaA, Gilead Sciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
  • Chapter 2: Revenue of Oncology Drugs in global and regional level.
  • Chapter 3: Detailed analysis of Oncology Drugs company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oncology Drugs revenue, gross margin, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion

FAQ for this report

What is the Oncology Drugs Market size in 2030?

Ans: The Oncology Drugs Market size in 2030 will be US$ 395270 million.

What is the Roche, Celgene, Novartis share in Oncology Drugs Market?

Ans: The industry's leading producers include Roche, Celgene and Novartis, which together account for 35% of their revenues.

What is the Oncology Drugs Market share by region?

Ans: By region, North America had the highest share of income, at 43%.

Who are the main players in the Oncology Drugs Market report?

Ans: The main players in the Oncology Drugs Market are Roche, Celgene, Novartis, Bristol-Myers Squibb, Johnson & Johnson, Merck & Co., AstraZeneca, Pfizer, Amgen, Eli Lilly, AbbVie, Takeda, Astellas, Ipsen, Sanofi, Bayer, Biogen Idec, Teva, Otsuka, Eisai, Merck KGaA, Gilead Sciences

What are the Application segmentation covered in the Oncology Drugs Market report?

Ans: The Applications covered in the Oncology Drugs Market report are Blood Cancer, Breast Cancer, Gastrointestinal Cancer, Prostate Cancer, Respiratory or Lung Cancer, Others

What are the Type segmentation covered in the Oncology Drugs Market report?

Ans: The Types covered in the Oncology Drugs Market report are Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy, Others

1 Study Coverage
1.1 Oncology Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Oncology Drugs Market Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Immunotherapy (Biologic Therapy)
1.2.5 Hormonal Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Oncology Drugs Market Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Respiratory or Lung Cancer
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Oncology Drugs Market Size Estimates and Forecasts
2.2 Oncology Drugs Market Size by Region: 2023 Versus 2030
2.2.1 Global Oncology Drugs Revenue by Region: 2019-2024
2.2.2 Global Oncology Drugs Revenue Forecast by Region (2025-2030)
2.2.3 Global Oncology Drugs Revenue Market Share by Region (2019-2030)
3 Global Oncology Drugs by Company
3.1 Global Oncology Drugs Revenue by Company (2019-2024)
3.2 Global Oncology Drugs Revenue Share by Company (2019-2024)
3.3 Competitive Landscape
3.3.1 Key Oncology Drugs Companies around the World: Ranking by Revenue
3.3.2 Global Oncology Drugs Market Concentration Ratio (CR5 and HHI) & (2019-2024)
3.3.3 Global Oncology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Oncology Drugs Companies Headquarters & Product Type
3.4.1 Oncology Drugs Companies Headquarters
3.4.2 Global Oncology Drugs Companies Product & Service
3.4.3 Date of International Companies Enter into Oncology Drugs Market
3.5 Global Oncology Drugs Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Roche
4.1.1 Roche Company Information
4.1.2 Roche Description, Business Overview
4.1.3 Roche Oncology Drugs Products Offered
4.1.4 Roche Oncology Drugs Revenue and Gross Margin (2019-2024)
4.1.5 Roche Oncology Drugs Revenue by Product in 2023
4.1.6 Roche Oncology Drugs Revenue by Application in 2023
4.1.7 Roche Oncology Drugs Revenue by Geographic Area in 2023
4.1.8 Roche Recent Developments
4.2 Celgene
4.2.1 Celgene Company Information
4.2.2 Celgene Description, Business Overview
4.2.3 Celgene Oncology Drugs Products Offered
4.2.4 Celgene Oncology Drugs Revenue and Gross Margin (2019-2024)
4.2.5 Celgene Oncology Drugs Revenue by Product in 2023
4.2.6 Celgene Oncology Drugs Revenue by Application in 2023
4.2.7 Celgene Oncology Drugs Revenue by Geographic Area in 2023
4.2.8 Celgene Recent Developments
4.3 Novartis
4.3.1 Novartis Company Information
4.3.2 Novartis Description, Business Overview
4.3.3 Novartis Oncology Drugs Products Offered
4.3.4 Novartis Oncology Drugs Revenue and Gross Margin (2019-2024)
4.3.5 Novartis Oncology Drugs Revenue by Product in 2023
4.3.6 Novartis Oncology Drugs Revenue by Application in 2023
4.3.7 Novartis Oncology Drugs Revenue by Geographic Area in 2023
4.3.8 Novartis Recent Developments
4.4 Bristol-Myers Squibb
4.4.1 Bristol-Myers Squibb Company Information
4.4.2 Bristol-Myers Squibb Description, Business Overview
4.4.3 Bristol-Myers Squibb Oncology Drugs Products Offered
4.4.4 Bristol-Myers Squibb Oncology Drugs Revenue and Gross Margin (2019-2024)
4.4.5 Bristol-Myers Squibb Oncology Drugs Revenue by Product in 2023
4.4.6 Bristol-Myers Squibb Oncology Drugs Revenue by Application in 2023
4.4.7 Bristol-Myers Squibb Oncology Drugs Revenue by Geographic Area in 2023
4.4.8 Bristol-Myers Squibb Recent Developments
4.5 Johnson & Johnson
4.5.1 Johnson & Johnson Company Information
4.5.2 Johnson & Johnson Description, Business Overview
4.5.3 Johnson & Johnson Oncology Drugs Products Offered
4.5.4 Johnson & Johnson Oncology Drugs Revenue and Gross Margin (2019-2024)
4.5.5 Johnson & Johnson Oncology Drugs Revenue by Product in 2023
4.5.6 Johnson & Johnson Oncology Drugs Revenue by Application in 2023
4.5.7 Johnson & Johnson Oncology Drugs Revenue by Geographic Area in 2023
4.5.8 Johnson & Johnson Recent Developments
4.6 Merck & Co.
4.6.1 Merck & Co. Company Information
4.6.2 Merck & Co. Description, Business Overview
4.6.3 Merck & Co. Oncology Drugs Products Offered
4.6.4 Merck & Co. Oncology Drugs Revenue and Gross Margin (2019-2024)
4.6.5 Merck & Co. Oncology Drugs Revenue by Product in 2023
4.6.6 Merck & Co. Oncology Drugs Revenue by Application in 2023
4.6.7 Merck & Co. Oncology Drugs Revenue by Geographic Area in 2023
4.6.8 Merck & Co. Recent Development
4.7 AstraZeneca
4.7.1 AstraZeneca Company Information
4.7.2 AstraZeneca Description, Business Overview
4.7.3 AstraZeneca Oncology Drugs Products Offered
4.7.4 AstraZeneca Oncology Drugs Revenue and Gross Margin (2019-2024)
4.7.5 AstraZeneca Oncology Drugs Revenue by Product in 2023
4.7.6 AstraZeneca Oncology Drugs Revenue by Application in 2023
4.7.7 AstraZeneca Oncology Drugs Revenue by Geographic Area in 2023
4.7.8 AstraZeneca Recent Development
4.8 Pfizer
4.8.1 Pfizer Company Information
4.8.2 Pfizer Description, Business Overview
4.8.3 Pfizer Oncology Drugs Products Offered
4.8.4 Pfizer Oncology Drugs Revenue and Gross Margin (2019-2024)
4.8.5 Pfizer Oncology Drugs Revenue by Product in 2023
4.8.6 Pfizer Oncology Drugs Revenue by Application in 2023
4.8.7 Pfizer Oncology Drugs Revenue by Geographic Area in 2023
4.8.8 Pfizer Recent Development
4.9 Amgen
4.9.1 Amgen Company Information
4.9.2 Amgen Description, Business Overview
4.9.3 Amgen Oncology Drugs Products Offered
4.9.4 Amgen Oncology Drugs Revenue and Gross Margin (2019-2024)
4.9.5 Amgen Oncology Drugs Revenue by Product in 2023
4.9.6 Amgen Oncology Drugs Revenue by Application in 2023
4.9.7 Amgen Oncology Drugs Revenue by Geographic Area in 2023
4.9.8 Amgen Recent Development
4.10 Eli Lilly
4.10.1 Eli Lilly Company Information
4.10.2 Eli Lilly Description, Business Overview
4.10.3 Eli Lilly Oncology Drugs Products Offered
4.10.4 Eli Lilly Oncology Drugs Revenue and Gross Margin (2019-2024)
4.10.5 Eli Lilly Oncology Drugs Revenue by Product in 2023
4.10.6 Eli Lilly Oncology Drugs Revenue by Application in 2023
4.10.7 Eli Lilly Oncology Drugs Revenue by Geographic Area in 2023
4.10.8 Eli Lilly Recent Development
4.11 AbbVie
4.11.1 AbbVie Company Information
4.11.2 AbbVie Description, Business Overview
4.11.3 AbbVie Oncology Drugs Products Offered
4.11.4 AbbVie Oncology Drugs Revenue and Gross Margin (2019-2024)
4.11.5 AbbVie Oncology Drugs Revenue by Product in 2023
4.11.6 AbbVie Oncology Drugs Revenue by Application in 2023
4.11.7 AbbVie Oncology Drugs Revenue by Geographic Area in 2023
4.11.8 AbbVie Recent Development
4.12 Takeda
4.12.1 Takeda Company Information
4.12.2 Takeda Description, Business Overview
4.12.3 Takeda Oncology Drugs Products Offered
4.12.4 Takeda Oncology Drugs Revenue and Gross Margin (2019-2024)
4.12.5 Takeda Oncology Drugs Revenue by Product in 2023
4.12.6 Takeda Oncology Drugs Revenue by Application in 2023
4.12.7 Takeda Oncology Drugs Revenue by Geographic Area in 2023
4.12.8 Takeda Recent Development
4.13 Astellas
4.13.1 Astellas Company Information
4.13.2 Astellas Description, Business Overview
4.13.3 Astellas Oncology Drugs Products Offered
4.13.4 Astellas Oncology Drugs Revenue and Gross Margin (2019-2024)
4.13.5 Astellas Oncology Drugs Revenue by Product in 2023
4.13.6 Astellas Oncology Drugs Revenue by Application in 2023
4.13.7 Astellas Oncology Drugs Revenue by Geographic Area in 2023
4.13.8 Astellas Recent Development
4.14 Ipsen
4.14.1 Ipsen Company Information
4.14.2 Ipsen Description, Business Overview
4.14.3 Ipsen Oncology Drugs Products Offered
4.14.4 Ipsen Oncology Drugs Revenue and Gross Margin (2019-2024)
4.14.5 Ipsen Oncology Drugs Revenue by Product in 2023
4.14.6 Ipsen Oncology Drugs Revenue by Application in 2023
4.14.7 Ipsen Oncology Drugs Revenue by Geographic Area in 2023
4.14.8 Ipsen Recent Development
4.15 Sanofi
4.15.1 Sanofi Company Information
4.15.2 Sanofi Description, Business Overview
4.15.3 Sanofi Oncology Drugs Products Offered
4.15.4 Sanofi Oncology Drugs Revenue and Gross Margin (2019-2024)
4.15.5 Sanofi Oncology Drugs Revenue by Product in 2023
4.15.6 Sanofi Oncology Drugs Revenue by Application in 2023
4.15.7 Sanofi Oncology Drugs Revenue by Geographic Area in 2023
4.15.8 Sanofi Recent Development
4.16 Bayer
4.16.1 Bayer Company Information
4.16.2 Bayer Description, Business Overview
4.16.3 Bayer Oncology Drugs Products Offered
4.16.4 Bayer Oncology Drugs Revenue and Gross Margin (2019-2024)
4.16.5 Bayer Oncology Drugs Revenue by Product in 2023
4.16.6 Bayer Oncology Drugs Revenue by Application in 2023
4.16.7 Bayer Oncology Drugs Revenue by Geographic Area in 2023
4.16.8 Bayer Recent Development
4.17 Biogen Idec
4.17.1 Biogen Idec Company Information
4.17.2 Biogen Idec Description, Business Overview
4.17.3 Biogen Idec Oncology Drugs Products Offered
4.17.4 Biogen Idec Oncology Drugs Revenue and Gross Margin (2019-2024)
4.17.5 Biogen Idec Oncology Drugs Revenue by Product in 2023
4.17.6 Biogen Idec Oncology Drugs Revenue by Application in 2023
4.17.7 Biogen Idec Oncology Drugs Revenue by Geographic Area in 2023
4.17.8 Biogen Idec Recent Development
4.18 Teva
4.18.1 Teva Company Information
4.18.2 Teva Description, Business Overview
4.18.3 Teva Oncology Drugs Products Offered
4.18.4 Teva Oncology Drugs Revenue and Gross Margin (2019-2024)
4.18.5 Teva Oncology Drugs Revenue by Product in 2023
4.18.6 Teva Oncology Drugs Revenue by Application in 2023
4.18.7 Teva Oncology Drugs Revenue by Geographic Area in 2023
4.18.8 Teva Recent Development
4.19 Otsuka
4.19.1 Otsuka Company Information
4.19.2 Otsuka Description, Business Overview
4.19.3 Otsuka Oncology Drugs Products Offered
4.19.4 Otsuka Oncology Drugs Revenue and Gross Margin (2019-2024)
4.19.5 Otsuka Oncology Drugs Revenue by Product in 2023
4.19.6 Otsuka Oncology Drugs Revenue by Application in 2023
4.19.7 Otsuka Oncology Drugs Revenue by Geographic Area in 2023
4.19.8 Otsuka Recent Development
4.20 Eisai
4.20.1 Eisai Company Information
4.20.2 Eisai Description, Business Overview
4.20.3 Eisai Oncology Drugs Products Offered
4.20.4 Eisai Oncology Drugs Revenue and Gross Margin (2019-2024)
4.20.5 Eisai Oncology Drugs Revenue by Product in 2023
4.20.6 Eisai Oncology Drugs Revenue by Application in 2023
4.20.7 Eisai Oncology Drugs Revenue by Geographic Area in 2023
4.20.8 Eisai Recent Development
4.21 Merck KGaA
4.21.1 Merck KGaA Company Information
4.21.2 Merck KGaA Description, Business Overview
4.21.3 Merck KGaA Oncology Drugs Products Offered
4.21.4 Merck KGaA Oncology Drugs Revenue and Gross Margin (2019-2024)
4.21.5 Merck KGaA Oncology Drugs Revenue by Product in 2023
4.21.6 Merck KGaA Oncology Drugs Revenue by Application in 2023
4.21.7 Merck KGaA Oncology Drugs Revenue by Geographic Area in 2023
4.21.8 Merck KGaA Recent Development
4.22 Gilead Sciences
4.22.1 Gilead Sciences Company Information
4.22.2 Gilead Sciences Description, Business Overview
4.22.3 Gilead Sciences Oncology Drugs Products Offered
4.22.4 Gilead Sciences Oncology Drugs Revenue and Gross Margin (2019-2024)
4.22.5 Gilead Sciences Oncology Drugs Revenue by Product in 2023
4.22.6 Gilead Sciences Oncology Drugs Revenue by Application in 2023
4.22.7 Gilead Sciences Oncology Drugs Revenue by Geographic Area in 2023
4.22.8 Gilead Sciences Recent Development
5 Breakdown Data by Type
5.1 Global Oncology Drugs Revenue by Type (2019-2024)
5.2 Global Oncology Drugs Revenue Forecast by Type (2025-2030)
5.3 Oncology Drugs Revenue Market Share by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Oncology Drugs Revenue by Application (2019-2024)
6.2 Global Oncology Drugs Revenue Forecast by Application (2025-2030)
6.3 Oncology Drugs Revenue Market Share by Application (2019-2030)
7 North America
7.1 North America Oncology Drugs Market Size YoY Growth 2019-2030
7.2 North America Oncology Drugs Market Facts & Figures by Country (2019-2030)
7.3 North America Oncology Drugs Revenue by Type (2019-2024)
7.4 North America Oncology Drugs Revenue by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Oncology Drugs Market Size YoY Growth 2019-2030
8.2 Asia-Pacific Oncology Drugs Market Facts & Figures by Region (2019-2030)
8.3 Asia-Pacific Oncology Drugs Revenue by Type (2019-2024)
8.4 Asia-Pacific Oncology Drugs Revenue by Application (2019-2024)
9 Europe
9.1 Europe Oncology Drugs Market Size YoY Growth 2019-2030
9.2 Europe Oncology Drugs Market Facts & Figures by Country (2019-2030)
9.3 Europe Oncology Drugs Revenue by Type (2019-2024)
9.4 Europe Oncology Drugs Revenue by Application (2019-2024)
10 Latin America
10.1 Latin America Oncology Drugs Market Size YoY Growth 2019-2030
10.2 Latin America Oncology Drugs Market Facts & Figures by Country (2019-2030)
10.3 Latin America Oncology Drugs Revenue by Type (2019-2024)
10.4 Latin America Oncology Drugs Revenue by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Oncology Drugs Market Size YoY Growth 2019-2030
11.2 Middle East and Africa Oncology Drugs Market Facts & Figures by Country (2019-2030)
11.3 Middle East and Africa Oncology Drugs Revenue by Type (2019-2024)
11.4 Middle East and Africa Oncology Drugs Revenue by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Oncology Drugs Supply Chain Analysis
12.2 Oncology Drugs Key Raw Materials and Upstream Suppliers
12.3 Oncology Drugs Clients Analysis
12.4 Oncology Drugs Sales Channel and Sales Model Analysis
12.4.1 Oncology Drugs Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Oncology Drugs Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Oncology Drugs Distributors
13 Market Dynamics
13.1 Oncology Drugs Industry Trends
13.2 Oncology Drugs Market Drivers
13.3 Oncology Drugs Market Challenges
13.4 Oncology Drugs Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
Roche
Astrazeneca plc
Sanofi
Novartis
Celgene
Bristol–Myers Squibb
Johnson & Johnson
Merck
Pfizer Inc
Amgen Inc
Eli Lilly
AbbVie
Takeda
Astellas
Ipsen S A
Bayer
Biogen Idec
TEVA
Otsuka
Eisai Co Ltd
Merck KGaA
Gilead Sciences
List of Tables
    Table 1. Global Oncology Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Major Companies of Chemotherapy
    Table 3. Major Companies of Targeted Therapy
    Table 4. Major Companies of Immunotherapy (Biologic Therapy)
    Table 5. Major Companies of Hormonal Therapy
    Table 6. Major Companies of Others
    Table 7. Global Oncology Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Oncology Drugs Market Size by Region (US$ Million): 2023 VS 2030
    Table 9. Global Oncology Drugs Revenue by Region (2019-2024) & (US$ Million)
    Table 10. Global Oncology Drugs Revenue Forecast by Region (2025-2030) & (US$ Million)
    Table 11. Oncology Drugs Revenue by Company (2019-2024) & (US$ Million)
    Table 12. Oncology Drugs Revenue Share by Company (2019-2024)
    Table 13. Ranking of Global Top Oncology Drugs Players by Revenue (US$ Million) in 2023
    Table 14. Global Oncology Drugs Companies Market Concentration Ratio (CR5 and HHI) & (2019-2024)
    Table 15. Global Oncology Drugs by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oncology Drugs as of 2023)
    Table 16. Global Oncology Drugs Companies Headquarters
    Table 17. Global Oncology Drugs Companies Product & Service
    Table 18. Date of International Companies Enter into Oncology Drugs Market
    Table 19. Global Oncology Drugs Mergers & Acquisitions, Expansion Plans
    Table 20. Roche Company Information
    Table 21. Roche Description and Business Overview
    Table 22. Roche Oncology Drugs Product
    Table 23. Roche Oncology Drugs Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 24. Roche Revenue Proportion of Oncology Drugs by Product in 2023
    Table 25. Roche Revenue Proportion of Oncology Drugs by Application in 2023
    Table 26. Roche Revenue Proportion of Oncology Drugs by Geographic Area in 2023
    Table 27. Roche Recent Development
    Table 28. Celgene Company Information
    Table 29. Celgene Description and Business Overview
    Table 30. Celgene Oncology Drugs Product
    Table 31. Celgene Oncology Drugs Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 32. Celgene Revenue Proportion of Oncology Drugs by Product in 2023
    Table 33. Celgene Revenue Proportion of Oncology Drugs by Application in 2023
    Table 34. Celgene Revenue Proportion of Oncology Drugs by Geographic Area in 2023
    Table 35. Celgene Recent Development
    Table 36. Novartis Company Information
    Table 37. Novartis Description and Business Overview
    Table 38. Novartis Oncology Drugs Product
    Table 39. Novartis Oncology Drugs Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 40. Novartis Revenue Proportion of Oncology Drugs by Product in 2023
    Table 41. Novartis Revenue Proportion of Oncology Drugs by Application in 2023
    Table 42. Novartis Revenue Proportion of Oncology Drugs by Geographic Area in 2023
    Table 43. Novartis Recent Development
    Table 44. Bristol-Myers Squibb Company Information
    Table 45. Bristol-Myers Squibb Description and Business Overview
    Table 46. Bristol-Myers Squibb Oncology Drugs Product
    Table 47. Bristol-Myers Squibb Oncology Drugs Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 48. Bristol-Myers Squibb Revenue Proportion of Oncology Drugs by Product in 2023
    Table 49. Bristol-Myers Squibb Revenue Proportion of Oncology Drugs by Application in 2023
    Table 50. Bristol-Myers Squibb Revenue Proportion of Oncology Drugs by Geographic Area in 2023
    Table 51. Bristol-Myers Squibb Recent Development
    Table 52. Johnson & Johnson Company Information
    Table 53. Johnson & Johnson Description and Business Overview
    Table 54. Johnson & Johnson Oncology Drugs Product
    Table 55. Johnson & Johnson Oncology Drugs Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 56. Johnson & Johnson Revenue Proportion of Oncology Drugs by Product in 2023
    Table 57. Johnson & Johnson Revenue Proportion of Oncology Drugs by Application in 2023
    Table 58. Johnson & Johnson Revenue Proportion of Oncology Drugs by Geographic Area in 2023
    Table 59. Johnson & Johnson Recent Development
    Table 60. Merck & Co. Company Information
    Table 61. Merck & Co. Description and Business Overview
    Table 62. Merck & Co. Oncology Drugs Product
    Table 63. Merck & Co. Oncology Drugs Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 64. Merck & Co. Revenue Proportion of Oncology Drugs by Product in 2023
    Table 65. Merck & Co. Revenue Proportion of Oncology Drugs by Application in 2023
    Table 66. Merck & Co. Revenue Proportion of Oncology Drugs by Geographic Area in 2023
    Table 67. Merck & Co. Recent Development
    Table 68. AstraZeneca Company Information
    Table 69. AstraZeneca Description and Business Overview
    Table 70. AstraZeneca Oncology Drugs Product
    Table 71. AstraZeneca Oncology Drugs Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 72. AstraZeneca Revenue Proportion of Oncology Drugs by Product in 2023
    Table 73. AstraZeneca Revenue Proportion of Oncology Drugs by Application in 2023
    Table 74. AstraZeneca Revenue Proportion of Oncology Drugs by Geographic Area in 2023
    Table 75. AstraZeneca Recent Development
    Table 76. Pfizer Company Information
    Table 77. Pfizer Description and Business Overview
    Table 78. Pfizer Oncology Drugs Product
    Table 79. Pfizer Oncology Drugs Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 80. Pfizer Revenue Proportion of Oncology Drugs by Product in 2023
    Table 81. Pfizer Revenue Proportion of Oncology Drugs by Application in 2023
    Table 82. Pfizer Revenue Proportion of Oncology Drugs by Geographic Area in 2023
    Table 83. Pfizer Recent Development
    Table 84. Amgen Company Information
    Table 85. Amgen Description and Business Overview
    Table 86. Amgen Oncology Drugs Product
    Table 87. Amgen Oncology Drugs Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 88. Amgen Revenue Proportion of Oncology Drugs by Product in 2023
    Table 89. Amgen Revenue Proportion of Oncology Drugs by Application in 2023
    Table 90. Amgen Revenue Proportion of Oncology Drugs by Geographic Area in 2023
    Table 91. Amgen Recent Development
    Table 92. Eli Lilly Company Information
    Table 93. Eli Lilly Description and Business Overview
    Table 94. Eli Lilly Oncology Drugs Product
    Table 95. Eli Lilly Oncology Drugs Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 96. Eli Lilly Revenue Proportion of Oncology Drugs by Product in 2023
    Table 97. Eli Lilly Revenue Proportion of Oncology Drugs by Application in 2023
    Table 98. Eli Lilly Revenue Proportion of Oncology Drugs by Geographic Area in 2023
    Table 99. Eli Lilly Recent Development
    Table 100. AbbVie Company Information
    Table 101. AbbVie Description and Business Overview
    Table 102. AbbVie Oncology Drugs Product
    Table 103. AbbVie Oncology Drugs Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 104. AbbVie Revenue Proportion of Oncology Drugs by Product in 2023
    Table 105. AbbVie Revenue Proportion of Oncology Drugs by Application in 2023
    Table 106. AbbVie Revenue Proportion of Oncology Drugs by Geographic Area in 2023
    Table 107. AbbVie Recent Development
    Table 108. Takeda Company Information
    Table 109. Takeda Description and Business Overview
    Table 110. Takeda Oncology Drugs Product
    Table 111. Takeda Oncology Drugs Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 112. Takeda Revenue Proportion of Oncology Drugs by Product in 2023
    Table 113. Takeda Revenue Proportion of Oncology Drugs by Application in 2023
    Table 114. Takeda Revenue Proportion of Oncology Drugs by Geographic Area in 2023
    Table 115. Takeda Recent Development
    Table 116. Astellas Company Information
    Table 117. Astellas Description and Business Overview
    Table 118. Astellas Oncology Drugs Product
    Table 119. Astellas Oncology Drugs Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 120. Astellas Revenue Proportion of Oncology Drugs by Product in 2023
    Table 121. Astellas Revenue Proportion of Oncology Drugs by Application in 2023
    Table 122. Astellas Revenue Proportion of Oncology Drugs by Geographic Area in 2023
    Table 123. Astellas Recent Development
    Table 124. Ipsen Company Information
    Table 125. Ipsen Description and Business Overview
    Table 126. Ipsen Oncology Drugs Product
    Table 127. Ipsen Oncology Drugs Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 128. Ipsen Revenue Proportion of Oncology Drugs by Product in 2023
    Table 129. Ipsen Revenue Proportion of Oncology Drugs by Application in 2023
    Table 130. Ipsen Revenue Proportion of Oncology Drugs by Geographic Area in 2023
    Table 131. Ipsen Recent Development
    Table 132. Sanofi Company Information
    Table 133. Sanofi Description and Business Overview
    Table 134. Sanofi Oncology Drugs Product
    Table 135. Sanofi Oncology Drugs Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 136. Sanofi Revenue Proportion of Oncology Drugs by Product in 2023
    Table 137. Sanofi Revenue Proportion of Oncology Drugs by Application in 2023
    Table 138. Sanofi Revenue Proportion of Oncology Drugs by Geographic Area in 2023
    Table 139. Sanofi Recent Development
    Table 140. Bayer Company Information
    Table 141. Bayer Description and Business Overview
    Table 142. Bayer Oncology Drugs Product
    Table 143. Bayer Oncology Drugs Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 144. Bayer Revenue Proportion of Oncology Drugs by Product in 2023
    Table 145. Bayer Revenue Proportion of Oncology Drugs by Application in 2023
    Table 146. Bayer Revenue Proportion of Oncology Drugs by Geographic Area in 2023
    Table 147. Bayer Recent Development
    Table 148. Biogen Idec Company Information
    Table 149. Biogen Idec Description and Business Overview
    Table 150. Biogen Idec Oncology Drugs Product
    Table 151. Biogen Idec Oncology Drugs Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 152. Biogen Idec Revenue Proportion of Oncology Drugs by Product in 2023
    Table 153. Biogen Idec Revenue Proportion of Oncology Drugs by Application in 2023
    Table 154. Biogen Idec Revenue Proportion of Oncology Drugs by Geographic Area in 2023
    Table 155. Biogen Idec Recent Development
    Table 156. Teva Company Information
    Table 157. Teva Description and Business Overview
    Table 158. Teva Oncology Drugs Product
    Table 159. Teva Oncology Drugs Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 160. Teva Revenue Proportion of Oncology Drugs by Product in 2023
    Table 161. Teva Revenue Proportion of Oncology Drugs by Application in 2023
    Table 162. Teva Revenue Proportion of Oncology Drugs by Geographic Area in 2023
    Table 163. Teva Recent Development
    Table 164. Otsuka Company Information
    Table 165. Otsuka Description and Business Overview
    Table 166. Otsuka Oncology Drugs Product
    Table 167. Otsuka Oncology Drugs Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 168. Otsuka Revenue Proportion of Oncology Drugs by Product in 2023
    Table 169. Otsuka Revenue Proportion of Oncology Drugs by Application in 2023
    Table 170. Otsuka Revenue Proportion of Oncology Drugs by Geographic Area in 2023
    Table 171. Otsuka Recent Development
    Table 172. Eisai Company Information
    Table 173. Eisai Description and Business Overview
    Table 174. Eisai Oncology Drugs Product
    Table 175. Eisai Oncology Drugs Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 176. Eisai Revenue Proportion of Oncology Drugs by Product in 2023
    Table 177. Eisai Revenue Proportion of Oncology Drugs by Application in 2023
    Table 178. Eisai Revenue Proportion of Oncology Drugs by Geographic Area in 2023
    Table 179. Eisai Recent Development
    Table 180. Merck KGaA Company Information
    Table 181. Merck KGaA Description and Business Overview
    Table 182. Merck KGaA Oncology Drugs Product
    Table 183. Merck KGaA Oncology Drugs Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 184. Merck KGaA Revenue Proportion of Oncology Drugs by Product in 2023
    Table 185. Merck KGaA Revenue Proportion of Oncology Drugs by Application in 2023
    Table 186. Merck KGaA Revenue Proportion of Oncology Drugs by Geographic Area in 2023
    Table 187. Merck KGaA Recent Development
    Table 188. Gilead Sciences Company Information
    Table 189. Gilead Sciences Description and Business Overview
    Table 190. Gilead Sciences Oncology Drugs Product
    Table 191. Gilead Sciences Oncology Drugs Revenue (US$ Million) and Gross Margin (2019-2024)
    Table 192. Gilead Sciences Revenue Proportion of Oncology Drugs by Product in 2023
    Table 193. Gilead Sciences Revenue Proportion of Oncology Drugs by Application in 2023
    Table 194. Gilead Sciences Revenue Proportion of Oncology Drugs by Geographic Area in 2023
    Table 195. Gilead Sciences Recent Development
    Table 196. Global Oncology Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 197. Global Oncology Drugs Revenue Forecast by Type (2025-2030) & (US$ Million)
    Table 198. Global Oncology Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 199. Global Oncology Drugs Revenue Forecast by Application (2025-2030) & (US$ Million)
    Table 200. North America Oncology Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 201. North America Oncology Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 202. North America Oncology Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 203. North America Oncology Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 204. Asia-Pacific Oncology Drugs Revenue by Region (2019-2030) & (US$ Million)
    Table 205. Asia-Pacific Oncology Drugs Revenue by Region (2025-2030) & (US$ Million)
    Table 206. Asia-Pacific Oncology Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 207. Asia-Pacific Oncology Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 208. Europe Oncology Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 209. Europe Oncology Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 210. Europe Oncology Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 211. Europe Oncology Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 212. Latin America Oncology Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 213. Latin America Oncology Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 214. Latin America Oncology Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 215. Latin America Oncology Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 216. Middle East and Africa Oncology Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 217. Middle East and Africa Oncology Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 218. Middle East and Africa Oncology Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 219. Middle East and Africa Oncology Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 220. Oncology Drugs Key Raw Materials, Industry Status and Trend
    Table 221. Oncology Drugs Key Raw Materials and Upstream Suppliers
    Table 222. Oncology Drugs Clients Status and Trend
    Table 223. Oncology Drugs Typical Clients
    Table 224. Oncology Drugs Distributors
    Table 225. Oncology Drugs Market Trends
    Table 226. Oncology Drugs Market Drivers
    Table 227. Oncology Drugs Market Challenges
    Table 228. Oncology Drugs Market Restraints
    Table 229. Research Programs/Design for This Report
    Table 230. Key Data Information from Secondary Sources
    Table 231. Key Data Information from Primary Sources
List of Figures
    Figure 1. Oncology Drugs Product Picture
    Figure 2. Global Oncology Drugs Revenue Market Share by Type in 2023 & 2030
    Figure 3. Chemotherapy Product Picture
    Figure 4. Targeted Therapy Product Picture
    Figure 5. Immunotherapy (Biologic Therapy) Product Picture
    Figure 6. Hormonal Therapy Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Oncology Drugs Revenue Market Share by Application in 2023 & 2030
    Figure 9. Blood Cancer
    Figure 10. Breast Cancer
    Figure 11. Gastrointestinal Cancer
    Figure 12. Prostate Cancer
    Figure 13. Respiratory or Lung Cancer
    Figure 14. Others
    Figure 15. Oncology Drugs Report Years Considered
    Figure 16. Global Oncology Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 17. Global Oncology Drugs Market Size 2019-2030 (US$ Million)
    Figure 18. Global Oncology Drugs Market Size Market Share by Region: 2023 Versus 2030
    Figure 19. Global Oncology Drugs Revenue Market Share by Region (2019-2030)
    Figure 20. Oncology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 21. Global Oncology Drugs Revenue Market Share Forecast by Type (2019-2030)
    Figure 22. Global Oncology Drugs Revenue Market Share Forecast by Application (2019-2030)
    Figure 23. North America Oncology Drugs Revenue 2019-2030 (US$ Million)
    Figure 24. North America Oncology Drugs Revenue Market Share by Type (2019-2024)
    Figure 25. North America Oncology Drugs Revenue Market Share by Application (2019-2024)
    Figure 26. Asia-Pacific Oncology Drugs Revenue 2019-2030 (US$ Million)
    Figure 27. Asia-Pacific Oncology Drugs Revenue Market Share by Region (2019-2030)
    Figure 28. Asia-Pacific Oncology Drugs Revenue Market Share by Type (2019-2024)
    Figure 29. Asia-Pacific Oncology Drugs Revenue Market Share by Application (2019-2024)
    Figure 30. Europe Oncology Drugs Revenue Growth Rate 2019-2030 (US$ Million)
    Figure 31. Europe Oncology Drugs Revenue Market Share by Country (2019-2030)
    Figure 32. Europe Oncology Drugs Revenue Market Share by Type (2019-2024)
    Figure 33. Europe Oncology Drugs Revenue Market Share by Application (2019-2024)
    Figure 34. Latin America Oncology Drugs Revenue Growth Rate 2019-2030 (US$ Million)
    Figure 35. Latin America Oncology Drugs Revenue Market Share by Country (2019-2024)
    Figure 36. Latin America Oncology Drugs Revenue Market Share by Type (2019-2024)
    Figure 37. Latin America Oncology Drugs Revenue Market Share by Application (2019-2024)
    Figure 38. Middle East and Africa Oncology Drugs Revenue Growth Rate 2019-2030 (US$ Million)
    Figure 39. Middle East and Africa Oncology Drugs Revenue Market Share by Country (2019-2030)
    Figure 40. Middle East and Africa Oncology Drugs Revenue Market Share by Type (2019-2024)
    Figure 41. Middle East and Africa Oncology Drugs Revenue Market Share by Application (2019-2024)
    Figure 42. Oncology Drugs Supply Chain (Upstream and Downstream Market)
    Figure 43. Global Production Market Share of Oncology Drugs Raw Materials by Region in 2023
    Figure 44. Oncology Drugs Distribution Channels
    Figure 45. Global Oncology Drugs Percentage 2019-2030: Indirect Sales VS Direct Sales
    Figure 46. Global Oncology Drugs Percentage 2019-2030: Online Sales VS Offline Sales
    Figure 47. Bottom-up and Top-down Approaches for This Report
    Figure 48. Data Triangulation
    Figure 49. Key Executives Interviewed
    Figure 50. Global Oncology Drugs Percentage 2019-2030: Online Sales VS Offline Sales
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation
    Figure 53. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions